Get started
Author

Djelila Allouache

Observed names: D Allouache, D. Allouache, DJELILA ALLOUACHE, Djelila ALLOUACHE
Observed institutions: Lyon 1 Université, Institut Gustave Roussy, Centre Georges François Leclerc, Centre Hospitalier Universitaire de Tours, Centre François Baclesse, Centre Léon Bérard, Institut de Cancérologie de l'Ouest, Centre Eugène Marquis, Hôpital Lyon Sud, Centre Hospitalier Universitaire de Caen Normandie, Hôpital René Huguenin, Centre François Baclesse, Institut Claudius Regaud, Centre Oscar Lambret, Institut Bergonié, Institut Paoli-Calmettes, Centre Antoine Lacassagne, Institut Jean Godinot, Centre Henri Becquerel, Institut Curie
ORCID: 0009-0009-3693-3199
Observed ORCID: 0009-0009-3693-3199
OpenAlex ID: A5046156275
Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
2012 · Thomas Bachelot, Céline Bourgier, et al. · Journal of Clinical Oncology · 720
PDF
A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)
2019 · K. Fizazi, A. Maillard, et al. · Annals of Oncology · 261
HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients
2007 · Marianne Tuefferd, Jérôme Couturier, et al. · PLoS ONE · 192
PDF
Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment
2016 · Marie Lange, Natacha Heutte, et al. · The Oncologist · 131
One-Year Longitudinal Study of Fatigue, Cognitive Functions, and Quality of Life After Adjuvant Radiotherapy for Breast Cancer
2010 · Sabine Noal, Christelle Levy, et al. · International Journal of Radiation Oncology*Biology*Physics · 115
Baseline cognitive functions among elderly patients with localised breast cancer
2014 · Marie Lange, Bénédicte Giffard, et al. · European Journal of Cancer · 90
PDF
Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3‐arm randomized trial
2020 · Mélanie Dos Santos, Isabelle Hardy‐Léger, et al. · Cancer · 77
PDF
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours
2014 · C. Lévy, D. Allouache, et al. · Annals of Oncology · 60
Staging the axilla in breast cancer patients with 18F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?
2014 · Dimitri Bellevre, Cécile Blanc Fournier, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 58
PDF
Paclitaxel/carboplatin with or without belinostat as empiric first‐line treatment for patients with carcinoma of unknown primary site: A randomized, phase 2 trial
2015 · John D. Hainsworth, Gedske Daugaard, et al. · Cancer · 51
PDF
Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level
2018 · Joy Perrier, Armelle Viard, et al. · Brain Imaging and Behavior · 50
Early 2′-Deoxy-2′-[18F]Fluoro-d-Glucose PET Metabolic Response after Corticosteroid Therapy to Differentiate Cancer from Sarcoidosis and Sarcoid-like Lesions
2009 · Nicolas Aide, Djelila Allouache, et al. · Molecular Imaging and Biology · 43
Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer
2018 · Marie Lange, Natacha Heutte, et al. · The Oncologist · 37
PDF
Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer
2022 · Thomas Bachelot, Paul Cottu, et al. · Journal of Clinical Oncology · 34
5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study
2018 · A. Ploquin, B. Pistilli, et al. · European Journal of Cancer · 34
Final results from a phase III randomized clinical trial of adjuvant endocrine therapy ± chemotherapy in women ≥ 70 years old with ER+ HER2- breast cancer and a high genomic grade index: The Unicancer ASTER 70s trial.
2022 · Etienne Brain, Alessandro A. Viansone, et al. · Journal of Clinical Oncology · 32
First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
2005 · Djelila Allouache, Sulochana R Gawande, et al. · BMC Cancer · 28
PDF
HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer
2022 · François Cherifi, Angélique Da Silva, et al. · BMC Cancer · 25
PDF
Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib
2021 · George Emile, Sarah Penager, et al. · Oncology Letters · 20
PDF
HER2 Overexpression/Amplification and Trastuzumab Treatment in Advanced Ovarian Cancer: A GINECO Phase II Study
2009 · Isabelle Ray-Coquard, Jean Paul Guastalla, et al. · Clinical Ovarian Cancer · 20
Sleep macro- and microstructure in breast cancer survivors
2022 · J. Perrier, M. Duivon, et al. · Scientific Reports · 18
PDF
HER2 Overexpression/Amplification and Trastuzumab Treatment in Advanced Ovarian Cancer: A GINECO Phase II Study
2008 · Isabelle Ray-Coquard, Jean Paul Guastalla, et al. · Clinical Ovarian Cancer · 18
Pretreatment neutrophil to lymphocyte ratio as prognostic factor in metastatic breast cancer treated with cyclin dependent kinase 4/6 inhibitors
2023 · Pauline Rottier, Angélique DA SILVA, et al. · Frontiers in Oncology · 17
PDF
How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study
2015 · Julie Vanbockstael, Elodie Coquan, et al. · Supportive Care in Cancer · 17
Five-Year Analysis of the FNCLCC-PACS04 Trial: FEC100 vs ED75 for the Adjuvant Treatment of Node Positive Breast Cancer.
2009 · H. Roché, D. Allouache, et al. · Cancer Research · 14
Works count: 76
Citation count: 2,257
H-index: 20
I10-index: 26
Year
Topic
Type